Company profile

4D Molecular Therapeutics, Inc. Insider Trading

FDMT

Every SEC Form 4 insider trading filing for 4D Molecular Therapeutics, Inc. (FDMT) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
CIK
0001650648
Filings
90
Insiders
39
Last filing
2026-08-19

Activity summary

Recent insider activity is bullish. Over the last 30 days, 4 insiders purchased shares (net $14K). Buying was led by Bizily Scott.

Three year balance

Buy and sell value by quarter, Q4 23 to Q3 26. 4D Molecular Therapeutics, Inc. insiders are net sellers across the period shown.

Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $15.8M.

90 day insight

Over the last 90 days, 4D Molecular Therapeutics, Inc. insiders bought $95K (17 transactions) and sold $118K (1 transaction).

  • Most active insider: Bizily Scott with 14 transactions totaling $344K.
  • Largest single sale: $1.2M by Kirn David on Jun 22, 2026.
  • 92% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Aug 19, 2026Kirn DavidFDMT
Sale10b5
25,927$16.42$426K
Aug 19, 2026Kirn DavidFDMT
Option Exercise10b5
50,000
Aug 19, 2026Kirn DavidFDMT
Sale10b5
43,149$15.36$663K
Aug 19, 2026Kirn DavidFDMT
Option Exercise10b5
50,000$4.14$207K
Aug 17, 2026Bizily ScottFDMT
Option Exercise
1,635

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=FDMT" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Kirn DavidSee Remarks10 filings$3.2M
Bizily ScottChief Legal Officer11 filings$165K
Gupta AshooVP, Finance and Controller4 filings$7K

Institutional Ownership

Top 13F-HR holders of 4D Molecular Therapeutics, Inc. as of 2026-06-30

↓ decreasing
Total reported AUM
$123.9M
QoQ change
-72.3%
Reporting period
2026-06-30
#1
State Street Corp
CIK 0000093751
$38.7M
2.9M shares
#2
BlackRock, Inc.
CIK 0002012383
$29.4M
2.2M shares
#3
BlackRock, Inc.
CIK 0002012383
$20.3M
1.5M shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →